State Street Corp Exelixis, Inc. Transaction History
State Street Corp
- $2.8 Trillion
- Q3 2025
A detailed history of State Street Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, State Street Corp holds 11,114,815 shares of EXEL stock, worth $463 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,114,815
Previous 11,384,661
2.37%
Holding current value
$463 Million
Previous $502 Million
8.53%
% of portfolio
0.02%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding EXEL
# of Institutions
695Shares Held
257MCall Options Held
1.51MPut Options Held
1.71M-
Black Rock Inc. New York, NY33.5MShares$1.4 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.1MShares$1.09 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA19.5MShares$812 Million3.48% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.5MShares$644 Million0.9% of portfolio
-
Aqr Capital Management LLC Greenwich, CT9.18MShares$382 Million0.25% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $13.4B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...